PURE Bioscience Announces Ten Year $144 Million Contract - PURE Bioscience (OTC:PURE)

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

PURE Bioscience (NASDAQ: PURE) yesterday reported in its quarterly investor call that High Scope Trading LLC of Dubai has contractually committed to more than $144 million in orders over the next 10 years with an initial focus on sales of SDC-based IV-7 Water Treatment.

20-Year Pro Trader Reveals His "MoneyLine"

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!